Arcadia Biosciences Welcomes Dr. Randy Shultz as Head of Research and Development
— Experienced R&D strategist brings deep expertise in advanced breeding and gene editing technologies —
DAVIS, Calif. (April 9, 2019) – Arcadia Biosciences, Inc. (Nasdaq: RKDA), a food ingredient company and proven leader in agricultural innovation to improve the quality and nutritional content of crops, announced today that Randy Shultz, Ph.D. has joined the company’s leadership team as head of research and development.
Shultz has nearly 20 years of experience in plant science and agricultural biotechnology. The former global crop lead at Inari Agriculture, he also served there as the director of R&D and senior director of R&D strategy. Shultz was the first key scientific hire at Inari and played an instrumental role in building a scalable R&D platform and developing a foundational intellectual property estate. Before Inari, Shultz spent several years leading various scientific production teams at Monsanto (now Bayer Crop Science), including their Genome Editing Platform team.
“Throughout his career, Randy has established a reputation as a keen R&D strategist, driving products through the pipeline from invention through commercial planning,” said Raj Ketkar, Arcadia’s president and CEO. “With his deep expertise in gene editing and new plant breeding technologies, he will be exploring new partnerships and licensing opportunities to expand our platform of tools to improve crops. We are thrilled to have a science leader of Randy’s caliber as we build our capabilities in cannabis and advance future innovations in our GoodWheat portfolio of novel wheat attributes.”
“Arcadia is an innovative company with a strong technology foundation and rich pipeline of novel products,” said Shultz. “I look forward to working with Arcadia’s team of world-class scientists as we build the next generation of products, bringing value to growers and downstream partners.”
Shultz received his Ph.D. in functional genomics from North Carolina State University and his B.S. degree from the University of Wisconsin, Madison. He has authored over a dozen patents and publications.
About Arcadia Biosciences, Inc. Based in Davis, Calif., Arcadia Biosciences (Nasdaq: RKDA) develops agricultural products that create added value for farmers, enhance human health and improve the environmental sustainability of agriculture. Arcadia’s nutrition traits and products are aimed at creating healthier ingredients and whole foods with lower production costs. Arcadia’s agronomic performance traits are aimed at making agricultural production more economically efficient and environmentally sound. For more information, visit www.arcadiabio.com.
Note Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: the company’s expectations of Randy Shultz’s potential contributions as an executive on the leadership team; and the other risks set forth in the company’s filings with the Securities and Exchange Commission from time to time, including the risks set forth in the company’s Annual Report on Form 10-K for the year ended December 31, 2018. These forward-looking statements speak only as of the date hereof, and Arcadia Biosciences, Inc. disclaims any obligation to update these forward-looking statements.